KPT-9274, as a selective and allosteric PAK4 inhibitor, significantly inhibits the proliferation of pancreatic cancer cells with preference over normal human ductal epithelial (Aboukameel et al., 2017). Here, PAK4 is linked to familial pancreatic carcinoma.